Volume 19, Number 8—August 2013
Dispatch
Novel G10P[14] Rotavirus Strain, Northern Territory, Australia
Table 1
Case-patient specimen ID | Case-patient age | Date specimen collected | Location (postal code) of specimen collection† | Rotavirus vaccine (no. doses)‡ |
---|---|---|---|---|
V582 | 8 mo | Aug 13 | 0860 | Rotarix (2) |
WDP280 | 10 mo | Aug 19 | 0872 | Rotarix (2) |
V585 | 2 y | Aug 19 | 0860 | Rotarix (2) |
SA175 | 3 mo | Sep 2 | Unknown | Unknown |
SA179 | 4 mo | Sep 6 | 0872 | Rotarix (1) |
D355 | 84 y | Sep 11 | 0860 | Not applicable |
*ID, identification.
†Postal code zone 0860 encompasses Tennant Creek, Northern Territory; samples WDP280 and SA179 were collected in post code zone 0872, in communities near code zone 0860.
‡Rotarix, Glaxo SmithKlineBiologicals, Melbourne, Victoria, Australia.
1These authors contributed equally to this article.
Page created: July 19, 2013
Page updated: July 19, 2013
Page reviewed: July 19, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.